ArticleScientific reports2026
Hearing impairment and ocular complications in Zucker diabetic fatty rats: a cross-sectional study across disease progression.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
Diabetic retinopathy is a well-recognized microvascular complication of diabetes mellitus; however, diabetes-associated auditory dysfunction remains less well characterized, particularly with respect to its longitudinal progression. In this study, we performed a cross-sectional assessment of ocular and auditory function in Zucker diabetic fatty (ZDF) rats and examined their relationships with chronic hyperglycemia. Forty male ZDF (fa/fa) rats and thirty-two age-matched control rats (fa/-) were evaluated at 12, 20, 28, and 36 weeks of age. Ocular changes were assessed using slit-lamp microscopy and fluorescein fundus angiography, while auditory function was evaluated using auditory brainstem response (ABR) testing across frequencies from 4 to 32 kHz. Fasting blood glucose levels were monitored throughout the study. ZDF rats developed sustained hyperglycemia from 12 weeks of age onward. Elevated ABR thresholds were first observed at high frequencies (32 kHz) at 12 weeks, followed by progressive involvement of mid frequencies (16 and 24 kHz) at 20 weeks and all tested frequencies (4-32 kHz) at 28-36 weeks. Retinal vascular leakage and cataract formation increased with disease duration. Fasting blood glucose levels showed strong positive associations with ABR thresholds across all frequencies (r = 0.72-0.85, P < 0.01) and with cataract severity. These findings show that chronic hyperglycemia in ZDF rats is accompanied by progressive auditory and ocular dysfunction, providing longitudinal functional evidence of multisystem sensory impairment in a diabetic animal model.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.